Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 16 pseudogene 4 (KRT16P4) is a member of the keratin gene family within the human genome, specifically classified as a type I keratin pseudogene. Unlike its functional counterpart, keratin 16 (KRT16), KRT16P4 does not encode a protein product and is presumed nonfunctional. Keratin pseudogenes such as KRT16P4 arise from duplication or rearrangement of functional keratin genes but lack intact coding sequences. These pseudogenes are not involved in normal biological functions, disease pathways, or direct drug interactions, and they are generally excluded from lists of therapeutically relevant targets. Scientific reference to KRT16P4 primarily aids in genetic categorization and nomenclature and does not imply physiological activity[1][2].\n\nKRT16P4 is distinct from Keratin 16 (KRT16), which is an intermediate filament protein crucial for epithelial cell structure and is involved in skin barrier function, cell proliferation, and has been linked to genetic skin disorders such as pachyonychia congenita and palmoplantar keratoderma[3][4]. All functional and disease associations belong to KRT16, not KRT16P4.\n\nIn summary, **Keratin 16 pseudogene 4 (KRT16P4)** is a nonfunctional pseudogene with no encoded protein, biological activity, direct disease association, or relevance as a drug target. Any functional or disease role refers instead to the active Keratin 16 gene/protein[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 16 pseudogene 4 (KRT16P4).